With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Senti Biosciences, Inc.’s SNTI share price has surged by 6.40%, which has investors questioning if this is right time to sell ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 5.22%, which has investors questioning if this is right time to buy.

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 ...

Discovery Reveals Protein Involved in ... The scientists showed ... NK Cells Complexed With Bispecific Antibody Yield High Response Rates in Patients With Lymphoma Apr. 4, 2025 — A novel cell ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical app ...

Scientists have discovered a promising new way to slow down aging at the cellular level using a special type of whey protein ...

To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Northeastern University scientists have discovered that a protein in the human brain could potentially be used to grow new ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

These T cells took on a regulatory, anti-inflammatory role — essentially training the immune system to stay calm the next time it encountered the same substance. “This discovery adds evidence to our ...